¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Tylenol Allergy Sinus Medication Extra Strength Caplets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wound strength
    â»ó°­µµ
  • wet strength
    ½ÀÀ±ÀÎÀå°­µµ
  • yield strength
    Ç׺¹°­µµ, Ç׺¹¼¼±â
  • aortic sinus
    ´ëµ¿¸Æ±¼, ´ëµ¿¸Æµ¿
  • aortic sinus baroreceptor
    ´ëµ¿¸Æ±¼¾Ð·Â¼ö¿ë±â
  • aortic sinus fistula
    ´ëµ¿¸Æ±¼»û±æ, ´ëµ¿¸Æµ¿·ç
  • anal sinus
    Ç×¹®±¼, Ç×¹®µ¿
  • blood sinus
    Ç÷¾×±¼, Ç÷¾×µ¿
  • circular sinus
    °í¸®Á¤¸Æ±¼, À±»óÁ¤¸Æµ¿
  • coronary sinus
    °ü»óÁ¤¸Æµ¿, ½ÉÀåÁ¤¸Æ±¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ionic strength
    À̿°­µµ
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • marginal strength
    °æ°è°­µµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â, ÃÖ°í±â¿ï±â¼¼±â
  • physical strength
    ü·Â
  • strength
    Èû, ¼¼±â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • tearing strength
    °Áü¼¼±â, Àο­µµ
  • tensile strength
    ´ç±èÈû, ½ÅÀå°­µµ
  • tinting strength
    Âø»öÈû, Âø»ö·Â
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wet strength
    ½ÀÀ±µµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â.
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â(Úª×âîÜ¡­)
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â.
  • pollen allergy
    Áµa·ç<È­ºÐ>¾Ë·¹¸£±â.
  • Lactiferous sinus
    À¯ÁóºÐºñµ¿(êáñðÝÂÝôÔ×)
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • anal sinus
    Ç×¹®µ¿±¼
  • anterior sinus group
    ÀüºÎºñµ¿±º
  • aortic sinus
    ´ëµ¿¸Æµ¿±¼
  • aortic sinus aneurysm
    ´ëµ¿¸Æµ¿µ¿¸Æ·ù(ÓÞÔÑØæ÷ÓÔÑØæ×»).
  • aortic sinus baro(re)ceptor
    ´ëµ¿¸Æµ¿¾Ð¼ö¿ëü
  • aortic sinus fistula
    ´ëµ¿¸Æµ¿·ç.
  • aperture of frontal sinus
    À̸¶»Àµ¿±¼±¸¸Û
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • marginal strength
    ¿¬º¯°­µµ(æÞܫ˭öô).
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • muscle force =m. strength
    ±Ù ·Â(ÐÉæ³).
  • peak gradient strength
    ÃÖ°í °æ»ç ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • shearing strength
    Àü´Ü°­µµ(¡­Ë­öô).
  • strength
    °­µµ(Ë­öô), Èû, ¼¼±â.
  • strength duration curve
    °­µµ-±â°£°î¼±(Ë­ öôÑ¢ÊàÍØàÊ).
  • strength test
    °­µµ°Ë»ç
  • tearing strength
    Àο­µµ(ìÚæñöô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô)
  • tinting strength
    Âø»ö·Â(ó·ßäæ³).
  • ultimate strength
    ±ØÇѰ­µµ(пùÚË­öô) ¡ìÀç·áÀÇ¡í.
  • wet strength
    ½ÀÀ±µµ(ã¥ëÈöô), ½À°­µµ (ã¥Ë­öô).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Coronary sinus (partial)
    ½ÉÀåÁ¤¸Æµ¿±¼(ºÎºÐ)
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
  • Orifice of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼±¸¸Û
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æµ¿±¸
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇÏÃßüÁ¤¸Æµ¿
  • Groove for inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] ÇÏÃßüµ¿±¸
  • Inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇϽûóÁ¤¸Æµ¿
  • Definitive urogenital sinus
    ¿Ï¼ººñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿Ï¼º¿ä»ý½Äµ¿
  • Primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿ø½Ã¿ä»ý½Äµ¿
  • Superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »óÃßüÁ¤¸Æµ¿
  • Groove for superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »óÃßüµ¿±¸
  • Superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »ó½Ã»óÁ¤¸Æµ¿
  • Groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »ó½Ã»óµ¿±¸
  • Maxillary sinus branches
    À§Åε¿±¼°¡Áö
    [¿¾ ¿ë¾î] »ó¾Çµ¿Áö
  • Maxillary sinus
    À§ÅλÀµ¿±¼
    [¿¾ ¿ë¾î] »ó¾Çµ¿
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • umbilical sinus
    ¹è²Åµ¿, Á¦µ¿
  • urachal sinus
    ´¢¸·°üµ¿
  • urogenital sinus
    ºñ´¢»ý½Äµ¿, ¿ä»ý½Äµ¿
  • venous sinus
    Á¤¸Æµ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
BCM B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ...
DPM Diploma in Psychological Medicine; discontinue previous medication; Doctor of Physical Medicine; Doc...
MAIN medication-induced, autoimmune, infectious, and neoplastic [diseases associated with antiphospholipi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IS Ionic Strength
LISS Low ionic strength solutions
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • penicillin allergy
    Æä´Ï½Ç¸° ¾Ë·¯Áö, Æä´Ï½Ç¸° ¾Ë·¹¸£±â
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • physical strength
    ü·Â
  • shear strength
    Àü´Ü °­µµ
    µÚƲ¸®´Â Èû ¶Ç´Â Á¢¼±À» µû¶ó ¿òÁ÷ÀÌ´Â Èû¿¡ ÀúÇ×ÇÏ´Â ¼ºÁú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
medication systems, hospital Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.
(12 Dec 1998)
medication, vasodilator Drugs that act as blood vessel dilator (vasodilators) and open vessels by relaxing their muscular walls). For example, nitroglycerin is a vasodilator. So are the ace (angiotensin-converting enzyme) inhibitors.
(12 Dec 1998)
cholinergic medication <pharmacology> Medications which stimulate cholinergic receptors (for example bethanechol).
(15 Jan 1998)
preanesthetic medication Drugs administered prior to an anaesthetic to decrease anxiety and to obtain a smoother induction of, maintenance of, and emergence from anaesthesia.
(05 Mar 2000)
self medication The self administration of medication not prescribed by a physician or in a manner not directed by a physician.
(12 Dec 1998)
sublingual medication A drug dosage form intended to be used by placement under the tongue; the drug (e.g., nitroglycerin) is absorbed from the mucosal tissues and bypasses the gastrointestinal tract, where it may be partially or totally degraded.
(05 Mar 2000)
ionic medication Movement of ions as a result of an applied electric field. For example the delivery of a charged molecule from the end of a micropipette without hydraulic flow.
(18 Nov 1997)
thrombolytic medication Medications that dissolve blot clots (for example streptokinase, tissue plasminogen activator or TPA and urokinase).
(27 Sep 1997)
allergy 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy.
The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury.
2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders.
(18 Nov 1997)
allergy and immunology A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.
(12 Dec 1998)
allergy desensitization Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and injections ( shots ) are usually required for 3-5 years.
(12 Dec 1998)
allergy shots See Allergy desensitization.
(12 Dec 1998)
allergy skin test Test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable.
(12 Dec 1998)
allergy testing <investigation> A common method of screening a patient for potential allergies. May be given as a patch or a skin test (injection).
(27 Sep 1997)
atopic allergy <immunology> An allergic reaction with strong family tendencies.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á